A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...

Soterix Medical Inc., the global leader in non-invasive stimulation and integrated brain monitoring technologies, announced today clearance from the U.S. Food & Drug Administration (FDA) for the SPRY ...

New research suggests that paralyzed patients could regain some degree of movement — perhaps even walk again. In a study led by EPFL (Swiss Federal Technology Institute of Lausanne) and Lausanne ...

PureLee Redefined, a medical spa in Colorado Springs, has introduced Exomind mental wellness therapy, an FDA-cleared brain ...

MINNEAPOLIS, Minnesota — The U.S. Food and Drug Administration approved a Medtronic deep brain stimulation treatment to treat obsessive compulsive disorder – the first deep brain stimulation treatment ...

Mental wellness crisis: Stress and emotional fatigue have overtaken cancer as the top health concern in North America. A new solution: Exomind utilizes an advanced form of Transcranial Magnetic ...

Transcranial magnetic stimulation (TMS) typically requires daily clinic visits over six to eight weeks, a rather rigorous ...

Vagus nerve stimulation may treat many diseases by changing brain signals, inflammation, and organ communication.

Scientists at EPFL have developed an innovative, non-invasive brain stimulation therapy to significantly improve visual function in stroke patients who have suffered vision loss following a stroke.

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...